• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53介导的头颈部鳞状细胞癌对放疗的敏感性。

p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.

作者信息

Pirollo K F, Hao Z, Rait A, Jang Y J, Fee W E, Ryan P, Chiang Y, Chang E H

机构信息

Department of Surgery, Stanford University, California 94305-5328, USA.

出版信息

Oncogene. 1997 Apr 10;14(14):1735-46. doi: 10.1038/sj.onc.1201116.

DOI:10.1038/sj.onc.1201116
PMID:9135075
Abstract

Radiation resistant squamous cell carcinoma of the head and neck cell line JSQ-3 carries a mutant form of tumor suppressor gene p53. Treatment of these cells with an adenoviral vector containing wild-type p53 (Av1p53) was able to inhibit their growth in vitro and in vivo while having no effect on normal cells. More significantly, introduction of wtp53 also reduced the radiation-resistance level of this cell line in vitro, in a viral dose-dependent manner. Furthermore, this radiosensitization also carried over to the in vivo situation where the response of JSQ-3 cell-induced mouse xenografts to radiotherapy was markedly enhanced after treatment with Av1p53. Complete, long-term regression of the tumors for up to 162 days was observed when a single dose of Av1p53 was administered in combination with ionizing radiation, demonstrating the effectiveness of this combination of gene therapy and conventional radiotherapy. This sensitization of tumors to radiation therapy by replacement of wtp53 could significantly decrease the rate of recurrence after radiation treatment. Since radiation is one of the most prevalent forms of adjunctive therapy for a variety of cancers, these results have great relevance in moving toward an improved cancer therapy.

摘要

头颈部鳞状细胞癌抗辐射细胞系JSQ - 3携带一种肿瘤抑制基因p53的突变形式。用含有野生型p53的腺病毒载体(Av1p53)处理这些细胞,能够在体外和体内抑制其生长,而对正常细胞没有影响。更显著的是,引入野生型p53还能在体外以病毒剂量依赖的方式降低该细胞系的抗辐射水平。此外,这种放射增敏作用在体内也有体现,在用Av1p53处理后,JSQ - 3细胞诱导的小鼠异种移植瘤对放疗的反应明显增强。当单剂量的Av1p53与电离辐射联合使用时,观察到肿瘤完全、长期消退长达162天,证明了这种基因治疗与传统放疗联合的有效性。通过替换野生型p53使肿瘤对放射治疗敏感,可显著降低放疗后的复发率。由于放射是多种癌症最常用的辅助治疗形式之一,这些结果对于改进癌症治疗具有重要意义。

相似文献

1
p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.p53介导的头颈部鳞状细胞癌对放疗的敏感性。
Oncogene. 1997 Apr 10;14(14):1735-46. doi: 10.1038/sj.onc.1201116.
2
[Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].重组腺病毒-p53基因疗法联合放疗治疗头颈部鳞状细胞癌
Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):426-8.
3
In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.采用p53腺病毒对微小残留头颈鳞状细胞癌进行体内分子治疗。
Cancer Res. 1995 Jan 1;55(1):1-6.
4
Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.单纯疱疹病毒1型突变体(G207病毒)与放射联合用于治疗头颈部鳞状细胞癌
Eur J Cancer. 2005 Jan;41(2):313-22. doi: 10.1016/j.ejca.2004.10.018.
5
Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.视网膜母细胞瘤RB94增强头颈部鳞状细胞癌的放射治疗效果。
Clin Cancer Res. 2008 Jun 1;14(11):3514-9. doi: 10.1158/1078-0432.CCR-07-4538.
6
Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.从放射增敏和修复抑制潜力方面评估乏氧细胞放射增敏剂。取决于肿瘤细胞的p53状态以及对肿瘤内静止细胞的影响。
Anticancer Res. 2006 Mar-Apr;26(2A):1261-70.
7
Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.用表达单纯疱疹病毒胸苷激酶的溶瘤腺病毒治疗头颈部鳞状细胞癌。
Mol Ther. 2000 Jan;1(1):56-62. doi: 10.1006/mthe.1999.0014.
8
Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.p53基因治疗在人头颈鳞状细胞癌细胞系放疗或热疗中的作用
Oncol Rep. 2003 May-Jun;10(3):671-7.
9
Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.烷基磷脂哌立福新在细胞培养和异种移植中对鳞状细胞癌的放射增敏作用。
Clin Cancer Res. 2006 Mar 1;12(5):1615-22. doi: 10.1158/1078-0432.CCR-05-2033.
10
Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.腺病毒介导的p53基因疗法与紫杉醇在人类头颈癌、卵巢癌、前列腺癌和乳腺癌模型中具有协同疗效。
Clin Cancer Res. 1998 Apr;4(4):835-46.

引用本文的文献

1
Advances in radiotherapy and immunity in hepatocellular carcinoma.肝癌放射治疗与免疫治疗的进展。
J Transl Med. 2023 Aug 4;21(1):526. doi: 10.1186/s12967-023-04386-y.
2
p53 Modulates Radiosensitivity in Head and Neck Cancers-From Classic to Future Horizons.p53调节头颈癌的放射敏感性——从经典到未来展望
Diagnostics (Basel). 2022 Dec 5;12(12):3052. doi: 10.3390/diagnostics12123052.
3
Regression of Human Breast Carcinoma in Nude Mice after Ad Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis.腺病毒基因治疗后裸鼠人乳腺癌的消退由肿瘤血管内皮细胞凋亡介导。
Cancers (Basel). 2022 Dec 14;14(24):6175. doi: 10.3390/cancers14246175.
4
Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.恢复头颈部鳞状细胞癌中的p53功能以改善治疗效果。
Front Oncol. 2022 Jan 6;11:799993. doi: 10.3389/fonc.2021.799993. eCollection 2021.
5
Relationship between p53 status and the bioeffect of ionizing radiation.p53状态与电离辐射生物效应之间的关系。
Oncol Lett. 2021 Sep;22(3):661. doi: 10.3892/ol.2021.12922. Epub 2021 Jul 14.
6
Novel p53 therapies for head and neck cancer.用于头颈癌的新型p53疗法。
World J Otorhinolaryngol Head Neck Surg. 2016 Jul 19;2(2):68-75. doi: 10.1016/j.wjorl.2016.05.005. eCollection 2016 Jun.
7
Epstein-Barr Virus: Diseases Linked to Infection and Transformation.爱泼斯坦-巴尔病毒:与感染和转化相关的疾病
Front Microbiol. 2016 Oct 25;7:1602. doi: 10.3389/fmicb.2016.01602. eCollection 2016.
8
The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth.红色晶型硒纳米颗粒对头颈部鳞状细胞活力和生长的影响。
Int J Nanomedicine. 2016 Aug 1;11:3641-54. doi: 10.2147/IJN.S105173. eCollection 2016.
9
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.在胶质母细胞瘤小鼠模型中,将替莫唑胺包裹于肿瘤靶向纳米复合物中可增强抗癌疗效并降低毒性。
Cancer Lett. 2015 Dec 1;369(1):250-8. doi: 10.1016/j.canlet.2015.08.022. Epub 2015 Sep 2.
10
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.一种肿瘤靶向性p53纳米递送系统可限制对替莫唑胺的化疗耐药性,延长多形性胶质母细胞瘤小鼠模型的生存期。
Nanomedicine. 2015 Feb;11(2):301-11. doi: 10.1016/j.nano.2014.09.005. Epub 2014 Sep 18.